Fate Therapeutics Inc F6T.DU Stock
3.69 EUR
{{ price }}
-5.196814%
{{change_pct}}%
COUNTRY
Germany
Exchange
Dusseldorf
Market Cap
0 EUR
LOW - HIGH [24H]
3.69
-
3.73 EUR
VOLUME [24H]
563 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR
Fate Therapeutics Inc Price Chart
Fate Therapeutics Inc F6T.DU Financial and Trading Overview
| Fate Therapeutics Inc stock price | 3.69 EUR |
| Previous Close | 5.21 EUR |
| Open | 5.22 EUR |
| Bid | 5.23 EUR x N/A |
| Ask | 5.4 EUR x N/A |
| Day's Range | 5.22 - 5.22 EUR |
| 52 Week Range | 3.93 - 35.93 EUR |
| Volume | 340 EUR |
| Avg. Volume | 7 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
F6T.DU Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Fate Therapeutics Inc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 35.93 EUR |
| 52 Week Low | 3.93 EUR |
| 50-Day Moving Average | 5.08 EUR |
| 200-Day Moving Average | 12.15 EUR |
F6T.DU Share Statistics
| Avg. Volume (3 month) | 7 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Fate Therapeutics Inc Stock
What is a current F6T.DU stock price?
Fate Therapeutics Inc F6T.DU stock price today per share is 3.69 EUR.
How to purchase Fate Therapeutics Inc stock?
You can buy F6T.DU shares on the Dusseldorf exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fate Therapeutics Inc?
The stock symbol or ticker of Fate Therapeutics Inc is F6T.DU.
How many shares does Fate Therapeutics Inc have in circulation?
The max supply of Fate Therapeutics Inc shares is 0.
What is Fate Therapeutics Inc Price to Earnings Ratio (PE Ratio)?
Fate Therapeutics Inc PE Ratio is now.
What was Fate Therapeutics Inc earnings per share over the trailing 12 months (TTM)?
Fate Therapeutics Inc EPS is 0 EUR over the trailing 12 months.